Simone Borsani

Simone was born in Italy and obtained his master’s degree in molecular biology of the cell at the University of Milan. He then joined Gritti’s Lab at the SR-TIGET institute, working on the development and validation of an ex vivo gene therapy treatment to cure two rare neurodegenerative disorders called Sandhoff and Tay-Sachs diseases. He joined TVRU in 2024 and currently focuses on developing AAV-based gene therapies to treat rare genetic diseases mainly affecting the central nervous system.